Oncology and respiratory drug developer invoX Pharma is fine-tuning its pipeline and expects to cut about one-third of its employees, the company confirmed to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.